Par Pharmaceutical Companies, Inc.: Pharmaceuticals and Healthcare - Company Profile & SWOT Report
ICD Research's Par Pharmaceutical Companies, Inc.: Pharmaceuticals and Healthcare - Company Profile & SWOT Report contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, company history, mergers & acquisitions, recent developments, key employees as well as company locations and subsidiaries.
This report is a crucial resource for industry executives and anyone looking to access key information about Par Pharmaceutical Companies, Inc.
The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Examines and identifies key information and issues about Par Pharmaceutical Companies, Inc. for business intelligence requirements.
Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries.
Reasons To Buy
Quickly enhance your understanding of Par Pharmaceutical Companies, Inc.
Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
Increase business/sales activities by understanding your competitors’ businesses better.
Recognize potential partnerships and suppliers.
Par Pharmaceutical Companies, Inc. (Par Pharmaceutical) develops, manufactures, markets and distributes high-quality pharmaceuticals such as generic drugs and branded drugs for the US market. Its product portfoilio includes more than 50 products. The company has over 30 products in pipeline. The company conducts its manufacturing operations in the US. The company provides its products primarily to wholesalers, drug store chains, supermarket chains, mass merchandisers, distributors, mail order accounts, and government, principally through its internal staff. Its major customers include McKesson Drug Co., Cardinal Health, Inc., and AmerisourceBergen Corporation. Par Pharmaceutical is headquartered in Woodcliff Lake in New Jersey, the US.